________________________________________________________________________________________________________________________________

CO2 as resource for specialty chemicals:
What makes it difficult for industry

November 2015. Conversion of CO2 to valuable specialty chemicals (e.g. 3-hydroxy isobutyric acid, 3-HIBA) appears to be an exercise of translating available scientific research. Wonderful, if such a process is based on removing toxic waste (e.g. flue gases from steel works).

But, how to select and optimise one out of many promising microorganisms? What if, biotechnology, and even chemistry do not suffice to provide for efficiency and competitiveness of CO2 capture, storage, or finally conversion (e.g. by syngas)?

In the exclusive interview with B2Bioworld Peter Nagler, Head of International Innovation Evonik Industries answers challenging questions on provides an outlook beyond COP21 at Paris.

 

If you like to read this article, you can purchase it now

Please notice, when purchasing articles you agree to B2Bioworld's Terms and Conditions

Read Now - Please select your license (Prices incl. 7% VAT)

Article free of advertisement - 8 pages
- Includes current data on Germany’s CO2 production from industrial processes (e.g. Iron and Steel, or Cement); details on Evonik’s 2-HIBA producing microorganism, overview on bio-based glycerol used as platform chemical, and experimental data on fermenting with different CO2 purities

Full Company License enquire here

Back to section

Related Editorial Articles

B2Bioworld offers you background information

Renmatix: Modeling conversion of woody biomass at industrial scale

Sekisui Chemicals Taps Syngas Expertise

Bioeconomy offers Europe and Russia opportunity for long-term strategic cooperation
Esko Aho, Göran Persson, and Marc Palahí

Sustainability refers to more than “green” or “bio-based”
Giorgio Squinzi, President of construction chemicals corporation MAPEI SpA and of Italy’s Confindustria

Bio-based economy? What's in it for business
An industry perspective and key trends in an emerging lead market

Turkish Chemicals Industry: Opportunities and Threats
Timur Erk, President of TKSD on re-building Turkey’s chemicals industry

Plant Genetic Engineering: It's not as simple as Yes or No !
Nobel Prize winner Prof. Christiane Nüsslein-Volhard Warns of GMO-populism and researchers not standing up. Exclusive interview for readers of B2Bioworld

What Future for the Chemicals Industry?
Stefan Marcinowski, past Member of the Board of Executive Directors of BASF SE

Prospects of Enzyme Engineering and Biofuels Markets in Russia
Vladimir O. Popov, Director Bach Institute of Biochemistry, Moscow and EU liason person

The German Way towards Bio-Economy
Christine Lang, Co-Chair of the German Bioeconomy Council outlines perspectives beyond Germany

Cellulosic Ethanol Plant to Go or Not to Go
Steve Hartig, former General Manager for Licensing with POET-DSM, responsible for business development of Dutch DSM Bio-Based Products and Services details the business case

Resolving the Innovation Paradox
Günter von Au, Vice-Chairman of Board, Clariant AG and former CEO of Süd-Chemie. Includes an assessments of CHOREN’s failure and the Brazilian demand for cellulosic ethanol

Lobbying Lignocellulosic Ethanol Plants: “Some expectations were very aggressive…”
Christopher Standlee, VP Global Affairs for Abengoa on politics in the U.S., and his company’s strategic perspective on Brazil and Europe

Management of Innovation in the Chemicals Industry